These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35012874)

  • 1. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
    Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of germline genetic evaluation for prostate cancer.
    Loeb S; Li R; Sanchez Nolasco T; Byrne N; Cheng HH; Becker D; Leader AE; Giri VN
    Prostate; 2021 Aug; 81(11):754-764. PubMed ID: 34057231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J; McDougall C; Bowler N; Shimada A; Gross L; Hyatt C; Kelly WK; Calvaresi A; Handley NR; Hirsch IH; Izes JK; Lallas CD; Mann M; Mark JR; Mille PJ; Preate D; Trabulsi EJ; Tsang M; Chandrasekar T; Weiner PR; Gomella LG; Giri VN
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34589662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing.
    Loeb S; Keith SW; Cheng HH; Leader AE; Gross L; Sanchez Nolasco T; Byrne N; Hartman R; Brown LH; Pieczonka CM; Gomella LG; Kelly WK; Lallas CD; Handley N; Mille PJ; Mark JR; Brown GA; Chopra S; McClellan A; Wise DR; Hollifield L; Giri VN
    JCO Precis Oncol; 2024 Mar; 8():e2300552. PubMed ID: 38452310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S; Giri VN
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation
    Loeb S; Byrne N; Walter D; Makarov DV; Wise DR; Becker D; Giri VN
    Cancer Treat Res Commun; 2020; 25():100212. PubMed ID: 33091732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
    J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
    Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
    Greenberg S; Slager S; Neil BO; Cooney K; Maughan B; Stopa N; Venne V; Zickmund S; Colonna S
    Prostate; 2020 Apr; 80(5):441-450. PubMed ID: 32027768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
    Giri VN; Obeid E; Hegarty SE; Gross L; Bealin L; Hyatt C; Fang CY; Leader A
    Prostate; 2018 Sep; 78(12):879-888. PubMed ID: 29655297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
    Leader AE; Rebbeck TR; Oh WK; Patel AV; Winer EP; Bailey LO; Gomella LG; Lumpkins CY; Garraway IP; Aiello LB; Baskin ML; Cheng HH; Cooney KA; Ganzak A; George DJ; Halabi S; Hathaway F; Healy C; Kim JW; Leapman MS; Loeb S; Maxwell KN; McNair C; Morgan TM; Prindeville B; Soule HR; Steward WL; Suttiratana SC; Taplin ME; Yamoah K; Fortune T; Bennett K; Blanding-Godbolt J; Gross L; Giri VN
    BMC Public Health; 2024 Sep; 24(1):2533. PubMed ID: 39289635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician attitudes about genetic testing for localized prostate cancer: A national survey of radiation oncologists and urologists.
    Kim SP; Meropol NJ; Gross CP; Tilburt JC; Konety B; Yu JB; Abouassaly R; Weight CJ; Williams SB; Shah ND
    Urol Oncol; 2018 Nov; 36(11):501.e15-501.e21. PubMed ID: 30190177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
    Mark JR; McDougall C; Giri VN
    Urol Clin North Am; 2021 Aug; 48(3):311-322. PubMed ID: 34210487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
    Dron HA; Bucio D; Young JL; Tabor HK; Cho MK
    J Genet Couns; 2023 Feb; 32(1):166-181. PubMed ID: 36301246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and provider attitudes toward genomic testing for prostate cancer susceptibility: a mixed method study.
    Birmingham WC; Agarwal N; Kohlmann W; Aspinwall LG; Wang M; Bishoff J; Dechet C; Kinney AY
    BMC Health Serv Res; 2013 Jul; 13():279. PubMed ID: 23870420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
    Loeb S; Cheng HH; Leader A; Gross L; Nolasco TS; Byrne N; Wise DR; Hollifield L; Brown LH; Slater E; Pieczonka C; Gomella LG; Kelly WK; Trabulsi EJ; Handley N; Lallas CD; Chandrasekar T; Mille P; Mann M; Mark JR; Brown G; Chopra S; Wasserman J; Phillips J; Somers P; Giri VN
    Contemp Clin Trials; 2022 Aug; 119():106821. PubMed ID: 35710085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
    Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
    JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A National Survey of Radiation Oncologists and Urologists on Perceived Attitudes and Recommendations of Active Surveillance for Low-Risk Prostate Cancer.
    Kim SP; Tilburt JC; Shah ND; Yu JB; Konety B; Nguyen PL; Abouassaly R; Williams SB; Gross CP
    Clin Genitourin Cancer; 2019 Jun; 17(3):e472-e481. PubMed ID: 30827923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivering Genetic Testing for Patients with Prostate Cancer: Moving Beyond Provider Knowledge as a Barrier to Care.
    Gunn CM; Li EX; Gignac GA; Pankowska M; Loo S; Zayhowski K; Wang C
    Cancer Control; 2023; 30():10732748221143884. PubMed ID: 36946278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM; Facchini LA; Giri VN; Antonarakis ES; Beer TM; Carlo MI; Danila DC; Dhawan M; George D; Graff JN; Gupta S; Heath E; Higano CS; Liu G; Molina AM; Paller CJ; Patnaik A; Petrylak DP; Reichert Z; Rettig MB; Ryan CJ; Taplin ME; Vinson J; Whang YE; Morgans AK; Cheng HH; McKay RR
    JCO Oncol Pract; 2020 Dec; 16(12):811-819. PubMed ID: 32986533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.